Orange, Purple, and the Drugs Between Them

Orange, Purple, and the Drugs Between Them

Speaking Engagement
WilmerHale Intellectual Property Litigation Partner Andrew Danford will participate in the Boston Bar Association’s Orange, Purple, and the Drugs Between Them webinar on Thursday, May 9, discussing hot topics related to Hatch-Waxman and biosimilar litigation, including recent scrutiny from the FTC over what patents may be listed in the Orange Book.

Read More About the Event



Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.